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Introduction
Preimplantation stages of early mammalian embryonic
development lead to the formation of the blastocyst, which is
composed of the trophectoderm (TE), a single epithelial layer
that surrounds a fluid filled cavity (the blastocoel), and the
inner cell mass (ICM). One day prior to blastocyst formation,
the eight-cell embryo undergoes compaction, a morphogenetic
change characterized by the flattening of blastomeres against
each other and establishment of E-cadherin-dependent
basolateral cell-cell adhesion. Blastomeres acquire apicobasal
polarity typified by apical localization of microvilli and
acquisition of cytoplasmic polarity (Fleming et al., 2001; Pratt
et al., 1982; Reeve and Ziomek, 1981). In subsequent cell
divisions, outer cells remain polarized and generate the TE
epithelium. During blastocyst formation, the TE cells form a
transporting epithelium, with functional adherens and tight
junctions (Fleming et al., 2001). The activity of sodium pumps
(Na+, K+-ATPases) leads to establishment of ionic gradients
across the TE and accumulation of fluid in the forming
blastocoel cavity (Watson, 1992). In addition, aquaporins
contribute to water movements across the TE, leading to
blastocoel expansion (Barcroft et al., 2003). After hatching
from the zona pellucida, a subpopulation of TE cells – the
mural TE cells – exhibit increased protrusive activity and
undergo changes in cell polarity through relocalization of
proteins such as integrin α5β1 and integrin α7β1 from basal
to apical domains (reviewed by Sutherland et al., 2003). At this
stage, cells in the ICM have segregated into the epiblast, or
embryonic lineage, and the primitive endoderm (PE), or extra-
embryonic endoderm lineage.
Following implantation, cells overlying the ICM – the polar
TE – continue to proliferate and form the extra-embryonic
ectoderm (ExE) that contains trophoblast stem (TS) cells
(Tanaka et al., 1998) and the diploid ectoplacental cone (EPC),
while the mural cells cease division and form trophoblast giant
cells. Further differentiation of the trophoblast lineage
generates the labyrinth, spongiotrophoblast and glycogen cells
of the mature chorioallantoic placenta (Rossant and Cross,
2001).
Identification of the molecular components required for the
initial segregation of the TE and ICM lineages has been
elusive, as few mutations have been found to cause early
lineage-specific defects. Oct4 (Pou5f1), a POU domain
transcription factor (TF), is required for maintenance of ICM
fate and pluripotency of ES cells (Nichols et al., 1998; Niwa
et al., 2000). Oct4 is expressed in all blastomeres of the
cleavage stage embryo, but becomes restricted to the ICM after
initiation of blastocyst formation (Palmieri et al., 1994).
Homozygous mutant Oct4 embryos develop to the blastocyst
stage, but their isolated ICM cells express trophectoderm
markers when outgrown in vitro (Nichols et al., 1998).
Furthermore, conditional repression of Oct4 in ES cells leads
Blastocyst formation marks the segregation of the first two
cell lineages in the mammalian preimplantation embryo:
the inner cell mass (ICM) that will form the embryo proper
and the trophectoderm (TE) that gives rise to the
trophoblast lineage. Commitment to ICM lineage is
attributed to the function of the two transcription factors,
Oct4 (encoded by Pou5f1) and Nanog. However, a positive
regulator of TE cell fate has not been described. The T-box
protein eomesodermin (Eomes) and the caudal-type
homeodomain protein Cdx2 are expressed in the TE, and
both Eomes and Cdx2 homozygous mutant embryos die
around the time of implantation. A block in early TE
differentiation occurs in Eomes mutant blastocysts.
However, Eomes mutant blastocysts implant, and Cdx2 and
Oct4 expression are correctly restricted to the ICM TE.
Blastocoel formation initiates in Cdx2 mutants but
epithelial integrity is not maintained and embryos fail to
implant. Loss of Cdx2 results in failure to downregulate
Oct4 and Nanog in outer cells of the blastocyst and
subsequent death of those cells. Thus, Cdx2 is essential for
segregation of the ICM and TE lineages at the blastocyst
stage by ensuring repression of Oct4 and Nanog in the TE.
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to differentiation into trophoblast morphology and an increase
in expression of trophoblast-specific markers (Niwa et al.,
2000; Hay et al., 2004). Culturing these cells under conditions
that promote trophoblast proliferation generated cells
apparently equivalent to TS cells (Niwa et al., 2000).
Nanog, a homeobox gene, is also expressed in the ICM at
3.5 days post-coitum (dpc) and becomes epiblast-specific in the
implanting blastocyst. Nanog maintains ES cell pluripotency
independent of LIF signalling, and in the absence of Nanog,
ES cells and ICMs both differentiate into extra-embryonic
endoderm (Chambers et al., 2003; Mitsui et al., 2003). Thus,
Nanog has been implicated in repressing the extra-embryonic
endoderm or PE fate, while Oct4 may function as a repressor
of the trophoblast cell fate.
Only a few TFs show TE-specific expression at the
blastocyst stage (Beck et al., 1995; Hancock et al., 1999; Luo
et al., 1997; Rossant et al., 1998; Russ et al., 2000), and none
so far has shown absence of TE formation when mutated
(Guillemot et al., 1994; Luo et al., 1997; Russ et al., 2000). It
has been proposed that the TE develops by default in the
absence of Oct4 (Pesce and Scholer, 2001). However, TE
differentiation begins prior to downregulation of Oct4 in the
outer cells of the nascent blastocyst, suggesting that there
should also be positive acting factors promoting TE fate. Cdx2,
a caudal-type homeodomain TF, has been reported to be
specifically expressed in TE at blastocyst stage, and expression
is maintained within the proliferating ExE (Beck et al., 1995).
Heterozygous Cdx2 mutants show homeotic transformation
defects and homozygous mutants die at the peri-implantation
stage (Chawengsaksophak et al., 1997; Tamai et al., 1999).
Eomesodermin (Eomes), a T-box TF, is also expressed
specifically in the TE at the blastocyst stage, and, like Cdx2,
is expressed at later stages in the ExE (Ciruna and Rossant,
1999; Hancock et al., 1999; Russ et al., 2000). Eomes mutants
have also been reported to show early defects in trophoblast
proliferation (Russ et al., 2000).
In this paper, we compare the Cdx2–/– and Eomes–/– mutant
phenotypes in more detail, and show that Cdx2 mutant
blastocysts fail to maintain trophoblast differentiation and fail
to implant. Interestingly, loss of Cdx2 is associated with failure
to downregulate Oct4 and Nanog in outer cells of the blastocyst
and results in subsequent death of outer cells. By contrast,
Eomes mutants form blastocysts, display ICM-restricted Oct4
expression and TE-specific Cdx2 expression, but trophoblast
does not differentiate further. Thus, Cdx2 is the earliest TF
identified so far to be involved in specification of TE fate, and
Cdx2 is required for repression of Oct4/Nanog and normal
blastocyst development.
Materials and methods
Targeting and inactivation of Eomesodermin gene
Mouse Eomes genomic clones were isolated from a strain 129/sv
genomic library. To generate the deletion/replacement knockout
construct, a 3.4 kb EcoRI fragment encompassing exons 1 and 2 was
used as left homologous arm, and a 2.1 kb HindIII/XbaI fragment
containing 3′ UTR as right arm (as shown in Fig. 8A). Electroporated
R1 ES cell clones were doubly selected with G418 and gancylovir,
and screened for homologous recombination by Southern blot using
a 500 bp 5′ external probe and verified by a 3′ internal probe (not
shown). Two positive clones were aggregated with ICR morulae to
generate chimaeric mice, which were then mated with 129 females to
produce heterozygotes. Heterozygous knockout mice were maintained
in either a pure 129 or a 129/ICR mixed background; no difference
in phenotype was observed.
Mouse breeding, embryo collection and genotyping
Mice heterozygous for the Cdx2 targeted mutation Cdx2tm1Fbe
(MGI:1857928) (Chawengsaksophak et al., 1997) were maintained by
crossing to outbred ICR strain mice. Embryos were collected from
intercrossed Cdx2 or Eomes heterozygotes. Genotyping was
performed on individually isolated embryos directly or after
observation in culture or following in situ hybridization or antibody
staining. All genotyping was performed blind by PCR with primers
that produced both mutant and wild-type bands, thus ensuring
unequivocal identification of genotypes. The conditions of PCR
genotyping of mice and embryos for Cdx2 targeted mutation
Cdx2tm1Fbe were as previously described (Chawengsaksophak et al.,
1997). Eomes targeted mutants were genotyped using the following
primers (see also Fig. 8A): primer A, (forward primer) 5′-
GAAAGCGCCTGTCTCCAGCACCC-3′; primer B, (reverse primer)
5′-AACACTCCTGCGTCCTCCAGTCAC-3′; primer C, (Neor
forward primer) 5′-CAGCGCATCGCCTCTATCCGCC-3′. A 440 bp
amplification product is generated from the mutant allele between
primer C and B; a 350 bp product is amplified from the wild-type
allele between primers A and B.
RNA preparation and RT-PCR
RNA was isolated from single embryos as described (Chomczynski
and Sacchi, 1987). cDNA was reverse transcribed using Superscript
II reverse transcriptase according to manufacturer (Invitrogen). cDNA
was diluted 1/10 for semi-quantitative PCR. Minimum number of
cycles required for amplification by a given primer set was determined
on cDNA from single wild-type whole-embryo RNA preparation
cultured under the experimental conditions tested.
Primers used were as follows: β-actin, (forward) 5′-ggcccagagcaa-
gagaggtatcc-3′ and (reverse) 5′-acgcacgatttccctctcagc-3′ (30 cycles;
product size 460 bp); Cdx2, (forward) 5′-gcagtccctaggaagccaagtga-3′
and (reverse) 5′-ctctcggagagcccaagtgtg-3′ (35 cycles; product size 162
bp); Fgfr2, (forward) 5′-gacaagcccaccaactgcacc-3′ and (reverse) 5′-
cgtcccctgaagaacaagagc-3′ (40 cycles; product size 217 bp); Hand1,
(forward) 5′-atgaacctcgtgggcaggta-3′ and (reverse) 5′-tcactggtt-
tagctccagcg-3′ (40 cycles; product size 550 bp); Eomes, (forward) 5′-
gtgacagagacggtgtggagg-3′ and (reverse) 5′-agaggaggccgttggtctgtgg-3′
(35 cycles; products sizes 350 bp and 304 bp); Pl1 (Csh1 – Mouse
Genome Informatics) (forward) 5′-atcttctcagaaatgcagctg-3′ and
(reverse) 5′-gatcattgctttcagaaggtc-3′ (40 cycles; product size 336 bp).
In situ hybridization
Fluorescent in situ hybridization using digoxigenin- or FITC-
labelled RNA probes was performed according to
protocol available on the Rossant laboratory website:
http://www.mshri.on.ca/rossant/protocols/doubleFluor.html. RNA
antisense probes were in vitro transcribed from the following mouse
cDNA templates: Cdx2 (939 bp; Dr Peter Traber, PA); Oct4 (1336
bp; Dr Hitoshi Niwa, Japan); Nanog (981 bp; Dr Austin Smith, UK).
Immunohistochemistry
Immunohistochemistry protocols can be found on the Rossant
laboratory website (http://www.mshri.on.ca/rossant/protocols/
immunoStain.html). The following antibodies were used at the
following dilutions: affinity-purified polyclonal rabbit anti-Cdx2 
C-term and CNL (gift of Dr Edmond Rings) (Rings et al., 2001) 
1:500-1:1000 of 0.6 mg immunoglobulin/ml [specificity of anti-Cdx2
CNL was confirmed in blocking experiments as described by Silberg
et al. (Silberg et al., 2000)]; monoclonal anti-Cdx2 (CDX2-88,
BioGenex, CA, USA) 1:200; monoclonal mouse anti-Oct4 (C10; Santa
Cruz Biotechnology) 1:100; rabbit anti-Nanog (Mitsui et al., 2003; Dr
Yamanaka, NAIST, Japan) 1:400; monoclonal rat anti-integrin α7
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(undiluted CA5; gift of Dr
Ann Sutherland, University of
Virginia) (Klaffky et al., 2001);
rabbit anti-mouse ZO-1α+ 1:250;
rabbit anti-ZO-1α- at 1:250 (both
gifts of Dr Bhavwanti Sheth, UK);
and rat anti-E-cadherin (Sigma)
1:500. Secondary antibodies (Cy3
or Cy5-donkey anti-mouse; biotin
or Cy3-donkey anti-rabbit; 
Cy5-donkey anti-rat (Jackson
ImmunoResearch Laboratories)
were used at 1:300-1:400, and
Cy5-streptavidin at 1:1000. To
visualize nuclei, embryos were
incubated in YOYO-1 or YOYO-
3 (Molecular Probes) at 1:400-
1:1000 dilution with 10-20 µg/ml
RNAse A, for 15-30 minutes at
room temperature.
Embryo culture
To follow development in vitro,
eight-cell stage embryos were
flushed from oviducts in M2,
treated with acidic Tyrode’s to
remove zonae pellucidae (Nagy
et al., 2003). The embryos were
then cultured in microdrops of
KSOM-AA under mineral oil for
48 hours at 37°C, 5% CO2 and
transferred into microdrops of
RPMI 1640 containing 0.1%
BSA and 100 µM non-essential
amino acids for an additional 24
hours. For trophoblast outgrowth
formation, 3.5 dpc blastocysts
from heterozygous Cdx2 or
Eomes intercrosses were
individually cultured in KSOM-
AA overnight and then
transferred into RPMI 1640
containing 20% FCS in four-well
tissue culture dishes (Nunc, Denmark) untreated or pre-coated with
0.1% gelatin (Sigma), fibronectin (from bovine plasma, Sigma; 20
µg/ml in PBS) or laminin (Sigma; 25 µg/ml in PBS). Outgrowth
formation was monitored over 72-120 hours. For digital time-lapse
microscopy, embryos were collected and cultured in KSOM-AA in
glass-bottom dishes (MatTek, USA) overlaid with light mineral oil
and imaged using the Zeiss Axiovert 200 inverted microscope with
Incubator XL, Heating Insert P and CO2 controller. Temperature and
CO2 were set to 37.5°C and 5.5%, respectively. DIC images were
recorded, with halogen lamp voltage (<2.5 V), every 30 minutes using
AxioCam MRm with Axiovision 3.1 software.
TS cell culture and derivation
Derivation of trophoblast stem (TS) cell lines from blastocysts from
heterozygous Cdx2 or Eomes intercrosses was performed as
previously described (Tanaka et al., 1998) and as detailed at
http://www.mshri.on.ca/rossant/protocols/TScells.html. Genotyping
of cell lines was performed by PCR (for Cdx2) or confirmed by
Southern analysis (for Eomes).
TUNEL staining
Eight-cell embryos were cultured in KSOM-AA for 48 hours, then
fixed in 4% paraformaldehyde in PBS for 1 hour at room temperature,
and washed in PBS+0.1% Tween 20, incubated in TUNEL reaction
mixture (Roche) for 60 minutes at 37°C and washed as above. The
total number of FITC-labelled/TUNEL-positive nuclei in each
embryo was scored as well as their distribution in the ICM or TE by
counting multiple stacked optical sections.
Results
Cdx2 expression is detected in the trophectoderm
prior to implantation
Cdx2 expression was previously reported in the TE of the
blastocyst and the trophoblast lineage during post-implantation
stages (Beck et al., 1995). To gain better insight into the role
of Cdx2 in early development of the trophoblast lineage, we
followed the spatial and temporal dynamics of Cdx2
expression from the early morula stage to 5.5 dpc (Fig. 1). By
RT-PCR analysis, Cdx2 mRNA was first detected at the eight-
cell stage (not shown), and Cdx2 protein was first clearly
detected in the nucleus and cytoplasm of the outer cells of early
morula (~16 cells, n=4; Fig. 1A,B) and late morula stages (~25
cells, n=4; Fig. 1C,D). Some low level of expression was seen
cytoplasmically throughout the rest of the embryo.
Interestingly, at these stages Oct4 protein is present equally in
Fig. 1. Cdx2 is expressed in cells of the TE lineage. (A) DIC image of late morula stage embryo (~16 cell).
(B) Immunofluorescent localization of Cdx2 in embryo shown in A. Monoclonal anti-Cdx2 antibody
detects high levels of Cdx2 in nuclei of outer cells (arrow) and lower cytoplasmic levels (arrowhead). (C)
Polyclonal anti-Cdx2 (CNL) antibody detects similar expression pattern, including cytoplasmic staining
(arrowhead) at late morula (~25 cell) stage. (D) Oct4 and Cdx2 protein in same embryo shown in C. Cdx2
(red) is restricted to outer cells, but Oct4 (green) is still detectable in all outer cells. Oct4 and Cdx2
colocalize in outer cells (e.g. black arrowhead). (E-I) Composite DIC confocal images of polyclonal anti-
Cdx2 staining of (E) 3.25 dpc early blastocyst, (F) 3.5 dpc blastocyst, (G) 4.5 dpc implanting blastocyst,
(H) 4.75 dpc and (I) 5.5 dpc. Arrow indicates nuclear staining, white arrowhead indicates cytoplasmic. Red
arrowheads demarcate polar TE. Bracket indicates ExE. (J) DIC image of Cdx2–/– morula. (K) Monoclonal
anti-Cdx2 staining of embryo shown in J. (L) DIC image of Cdx2–/– blastocyst. (M) Monoclonal anti-Cdx2
staining of embryo shown in L. (N) DIC image of wild-type blastocyst. (O) Monoclonal anti-Cdx2 staining
of embryo shown in N. Scale bar: 15 µm in A-G; 30 µm in H,I; 20 µm J-O.
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all cells of the embryo, and thus is co-expressed with Cdx2 in
the outer cells (Fig. 1D). At the early blastocyst stage, Cdx2
expression was more restricted to the outer cell layer (3.25 dpc
n=2; Fig. 1E). By the expanded blastocyst stage, Cdx2 protein
was exclusively localized to the TE nuclei (3.5 dpc, n=4; Fig.
1F). At 4.5 dpc, by the onset of implantation, Cdx2 protein
levels appeared to be reduced in the mural TE, but maintained
in the polar TE cells directly overlying the ICM (n=3; Fig. 1G).
At later stages, Cdx2 expression became confined to the polar
TE (nascent ExE) cells directly overlaying the epiblast (4.75
dpc, n=2; Fig. 1H). By 5.5 dpc both epiblast and ExE have
expanded, and intense Cdx2 expression spanned the first three
or four cell rows in the ExE adjacent to the epiblast (n=2; Fig.
1I). Cdx2 expression is thus associated with the initiation of
TE fate, and later specifically delineates the cells of the
trophoblast lineage that give rise to TS cells in the peri-
implantation embryo (Corson et al., 2003; Tanaka et al., 1998).
A similar expression profile was found for Cdx2 mRNA (see
Fig. S1 in the supplementary material).
To determine whether there is any maternal Cdx2 protein in
the early embryo, we examined Cdx2–/– embryos at early
morulae and blastocyst stages. There was no nuclear Cdx2
protein detectable in Cdx2 mutants at either stage (4 mutant
morulae, 5 mutant blastocysts; Fig. 1K,M), compared with
prominent nuclear expression in Cdx2+/+ embryos (Fig. 1O).
Some low level fluorescence was observable in the cytoplasm
of Cdx2–/– embryos but whether this is real signal or
background staining is unclear.
Cdx2–/– blastocysts fail to maintain blastocoel
Previous analysis revealed that Cdx2 homozygous mutant
embryos die around the time of implantation. Dissection and
genotyping of post-implantation stages revealed neither
evidence of Cdx2–/– mutants nor any empty deciduae, which is
indicative of death prior to implantation (Chawengsaksophak et
al., 1997). We examined the morphology of embryos from
Cdx2+/– intercrosses by dissection from the uterus at 4.5 dpc.
Cdx2+/+ or Cdx2+/– blastocysts were recovered and were fully
expanded and hatched from their zonae pellucida by this stage
(n=10). By contrast, Cdx2–/– embryos recovered were still
enclosed in their zonae, and had little or no blastocoelic cavity
(n=4). Blastocyst formation was monitored by culturing zona-
free eight-cell stage embryos from Cdx2+/– intercrosses over a
time course of 72 hours (Fig. 2). Between 24 and 48 hours, all
embryos had a blastocoel. However, by 72 hours all Cdx2
mutants (n=4) showed no blastocoelic cavity and surface
morphology was rough. Live imaging of litters from Cdx2 +/–
intercrosses revealed that the blastocoel of Cdx2 mutants initially
expanded, but began to collapse around the time that non-mutant
littermates hatch from the zona (three mutants, 18 non-mutants;
see Movie 1 in the supplementary material). This collapse was
accompanied by a morphological change in the TE, as cells
acquired a rounded, non-epithelial appearance.
The trophectoderm of Cdx2 homozygous mutant
blastocysts fails to maintain epithelial integrity
To evaluate the degree of TE differentiation in Cdx2–/–
embryos, we examined the expression of TE-specific markers.
One of the characteristics of the TE epithelium is the formation
of tight junctions between the TE cells, which facilitate the
maintenance of the blastocoel cavity. As Cdx2 homozygous
mutants fail to maintain an expanded blastocoel, we examined
the expression of the tight junction and adherens junction
components in Cdx2 mutant embryos during development. ZO-
1α– and ZO-1α+ (encoded by Tjp1) incorporate into tight
junctions early and late during TE formation, respectively
(Sheth et al., 1997). E-cadherin localization to the basolateral
adherens junctions precedes tight junction formation (reviewed
by Fleming et al., 2000; Fleming et al., 2001). Both tight and
adherens junctions appeared grossly normal in early
blastocysts of both mutant and non-mutant genotype, as
assessed by expression of ZO-1α+ (four mutants, 15 non-
mutants; Fig. 3A,B), ZO-1α- (six mutants, 21 non-mutants; not
shown), and E-cadherin (10 mutants, 46 non-mutants; Fig.
3C,D). By contrast, both tight and adherens junctions appeared
abnormal in most mutants by the late blastocyst stage. In
particular, ZO-1α+ appeared patchy or diffuse compared with
littermates (7/8 mutants; 12 non-mutants; Fig. 3E,F), while
ZO-1α- was diffuse (3/3 mutants, five non-mutants; not
shown). E-cadherin expression was still observed in Cdx2–/–
blastocysts but appeared to be
mislocalized basally in some
cells of the TE (6/6 mutants, 13
non-mutants; Fig. 3G,H). These
observations suggest that the
polarity and integrity of the TE
epithelium, while initially
normal, is not maintained in the
absence of zygotic Cdx2.
Consistent with these
observations, the later polarity
marker integrin α7 (Itga7)
(Klaffky et al., 2001) was
undetectable in abnormal,
collapsed Cdx2 mutant at 4.5
dpc (Fig. 4E). Interestingly,
Oct4 appeared to be expressed
in all cells of Cdx2–/– embryos
at this stage (Fig. 4E; see
below).
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Fig. 2. Cultured Cdx2–/– embryos fail to form an expanded blastocyst. Bright-field images of Cdx2+/+
embryos (A-D) and Cdx2–/– embryos (E-I). Eight-cell embryos from Cdx2+/– intercrosses were
individually cultured, monitored for 72 hours, and images recorded at (A,E) 6 hours; (B,F) 24 hours; (G)
30 hours; (C,H) 48 hours; and (D,I) 72 hours. Scale bars: 25 µm.
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Expression of TE markers is compromised in
Cdx2–/– embryos
To investigate the fate of TE cells in Cdx2–/– embryos, we
followed the expression of additional TE markers by a semi-
quantitative RT-PCR analysis from individual in vitro cultured
blastocysts from Cdx2+/– intercrosses. Analysis was performed
on embryos prior to culture (3.5 dpc), at 24 hours and 72 hours
of culture (Fig. 4J). Cdx2–/– embryos expressed the TE
markers, Eomes and Fgfr2 (Haffner-Krausz et al., 1999; Russ
et al., 2000), although the expression levels of Eomes were
markedly lower in Cdx2 presumptive null embryos than in
littermates. The expression of Hand1 and Pl1 (Csh – Mouse
Genome Informatics) (Cross et al., 1995; Faria et al., 1991),
markers of differentiated trophoblast giant cells, was
undetectable in Cdx2–/– embryos, although these markers were
detected in Cdx2+/+ and Cdx2+/– embryos (Fig. 4J). Altogether,
TE-specific marker analysis indicated that, although blastocyst
formation begins in Cdx2–/– embryos, trophoblast
Fig. 3. Epithelial integrity of the TE is not maintained in Cdx2
mutant embryos. (A) Immunolocalization of ZO-1α+ in Cdx2+/–
early blastocyst. (B) ZO-1α + in Cdx2–/– early blastocyst. (C)
Immunolocalization of E-cadherin in wild type embryo shown in A.
(D) E-cadherin in Cdx2–/– embryo shown in B. (E) ZO-1α + in
Cdx2+/– late blastocyst. (F) ZO-1α + in extreme example of a Cdx2–/–
late blastocyst. (G) E-cadherin in Cdx2+/– late blastocyst. (H) E-
cadherin in typical Cdx2–/– late blastocyst. (A-F) Projections of
multiple optical sections. (G,H) Single sections.
Fig. 4. Reduced expression of trophectoderm markers in Cdx2–/–
blastocysts. (A) DIC image of Cdx2+/+ 4.5 dpc blastocyst. Mural TE
(mTE), polar TE (pTE), inner cell mass (ICM) and primitive endoderm
(PE, arrowheads) indicated. (B) Immunolocalization of Oct4 (red),
integrin α7 (blue) in embryo shown in A. Oct4 levels are reduced in the
PE (arrows). Integrin α7 is specifically expressed in the trophectoderm
(arrowheads in B,C). (C) Composite image of B and YOYO-1 (green,
nuclear staining) (B and C are single optical sections). (D) DIC image
of Cdx2–/– 4.5 dpc, a littermate of the embryo shown in A, encased in
its zona pellucida (arrowhead). (E) Oct4 (red) and integrin α7 (blue) in
embryo shown in D. Integrin α7 expression is undetectable, while Oct4
expression is found in almost all cells (compare E with F). (F) YOYO-1
(green) staining in embryo shown in D,E. Many nuclei are fragmented
(e.g. arrowhead) (E,F are projected image composed of 10 confocal
optical sections). Scale bars: 20 µm. (G-I) Trophoblast outgrowth
formation assay. Blastocysts (3.5 dpc) from Cdx2+/– intercrosses were
individually cultured in tissue culture plates uncoated or pre-coated
with ECM substrate. (G) Outgrowth of a Cdx2+/– embryo. (H,I) Cdx2–/–
embryos failed to attach, and formed a rounded mass of cells devoid of
a typical blastocoel. Parietal endoderm cells were detected in some
Cdx2–/– embryos cultures (K; arrowheads). Scale bars: 50µm. GC,
trophoblast giant cells. (J) Semi-quantitative RT-PCR analysis for
trophoblast markers in individual embryos from Cdx2+/– intercrosses.
RNA was extracted from individually cultured blastocysts and analyzed
by RT-PCR. Culture conditions are indicated (top): non-cultured 3.5
dpc blastocyst (Blastocyst), 1 day in KSOM (+1d KSOM), additional
48 hours culture in presence of serum (+2d culture). Presumptive
genotype is indicated over each lane: wt/het, Cdx2+/+ or Cdx2+/–
embryo; null, Cdx2–/– embryo; C, control TS cell-derived RNA.
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differentiation is compromised beyond the expanded blastocyst
stage.
Cdx2 homozygous mutants fail to form trophoblast
giant cells or TS cell lines in vitro
To address whether, under in vitro culture conditions, the TE
of Cdx2–/– embryos could be promoted to differentiate, zona-
free 3.5 dpc blastocysts from Cdx2+/– intercrosses were
cultured in serum-containing medium or specific extracellular
matrix substrates (Fig. 4G-I). Although Cdx2+/– or Cdx2+/+
blastocysts attached and initiated TE outgrowth within 24-36
hours after plating in serum-containing medium, Cdx2–/–
blastocysts failed to attach regardless of the extracellular
matrix substrate used (fibronectin, gelatin, or laminin; see
Table 1). By 72 hours of culture, Cdx2+/– or Cdx2+/+ blastocysts
formed both ICM and trophoblast outgrowths, the latter
containing trophoblast giant cells with typical large nuclei and
cytoplasm (Fig. 4G). By contrast, Cdx2–/– embryos showed no
attachment and giant cell outgrowth, with only occasional
parietal endoderm-like cells attached to the substrate. Embryos
survived and grew into structures resembling embryoid bodies
(Fig. 4H,I). Indeed, ES cells can be derived from Cdx2–/–
blastocysts (Chawengsaksophak et al., 2004), indicating that
ICM development is not affected in these embryos. When we
attempted to derive TS cell lines (Tanaka et al., 1998) from
blastocysts obtained from Cdx2+/– intercrosses, 22 TS cell lines
were obtained from a total of 36 blastocysts initially cultured.
However, none were Cdx2–/– by genotype. Thus, Cdx2 is
required for all aspects of early TE development, both diploid
proliferation and polyploid giant cell development.
The pluripotency markers Oct4 and Nanog are
ectopically expressed in the putative TE of 3.5 dpc
Cdx2 mutant blastocysts
We examined the expression of the pluripotency-associated
genes Oct4 and Nanog to assess whether the outside cells of
Cdx2 mutants were correctly specified. At 3.5 dpc, Oct4 was
expressed in all cells of Cdx2–/– blastocysts, including the outer
cells, whereas Oct4 was restricted to the ICM in control
embryos (3/3 mutants, 3/3 non-mutants; Fig. 5A,B). As Oct4
is normally expressed in all cells prior to the blastocyst stage
and then downregulated in outer cells, these results suggest that
its downregulation in the TE requires expression of Cdx2.
Nanog was also expressed in the outside cells of Cdx2–/–
blastocysts (2/2 mutants, 4 non-mutants; Fig. 5C,D). It has
previously been reported that Nanog is expressed only in inside
cells of the late morula and then the ICM (Chambers et al.,
2003; Mitsui et al., 2003). If true, this would suggest that loss
of Cdx2 leads to ectopic activation of Nanog in outside cells.
Using antibody to detect Nanog protein, we found detectable
levels of nuclear Nanog in all cells of ~16-cell (n=13) and ~32-
cell (n=8) Cdx2+/+ and Cdx2+/– embryos (Fig. 6A; not shown).
Nanog was restricted to the ICM of Cdx2+/+ and Cdx2+/–
embryos by the early blastocyst stage (n=10; Fig. 6C). At this
stage, Nanog was detected at equivalent levels in TE and ICM
cells in Cdx2–/– embryos (n=5), (Fig. 6C,D). However, no
difference in Nanog expression was observed between non-
mutant and Cdx2–/– embryos (n=3) at earlier stages (Fig. 6A,B
and not shown). These results indicate that Cdx2 is also
required to ensure downregulation of Nanog, as well as Oct4,
in outer cells beginning around the early blastocyst stage.
Increased incidence of programmed cell death in
Cdx2–/– embryos at the expanded blastocyst stage
As mentioned above, the periphery of the 4.5 dpc Cdx2–/–
embryos showed a rough appearance with cells delaminating
from the embryonic mass surface. Moreover, nuclear staining
revealed fragmented, pyknotic nuclei, suggestive of cell death.
No such pyknotic nuclei were observed at earlier stages and
cell numbers of mutant versus wild-type embryos were similar
(not shown). To determine whether cell death is increased in
Cdx2–/– embryos, we cultured zona-free eight-cell stage
embryos from Cdx2+/– intercrosses, and monitored the degree
of cell death by a TUNEL assay after 48 hours of culture (Fig.
7). In Cdx2+/+ or Cdx2+/– embryos (n=16; Fig. 7A) cell death
was limited and almost all TUNEL-positive nuclei were within
the ICM (Fig. 7C). By contrast, in Cdx2–/– embryos (n=7; Fig.
7B,B′) a significantly higher number of TUNEL-positive
nuclei was detected, with an increase of three-fold and eight-
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Table 1. Cdx2–/– blastocysts plated on different substrata
fail to attach and form a trophoblast outgrowth
Cdx2 genotype*
ECM substrate +/+ +/– –/–†
Fibronectin 43/43 75/75 0/29(1)
Gelatin 5/5 10/10 0/4(1)
Laminin 12/12 13/13 0/7
No substrate 2/2 10/10 0/3
Blastocysts from Cdx2+/– heterozygous intercrosses were plated in serum-
containing medium on uncoated tissue culture dishes or pre-coated with
fibronectin, gelatin or laminin (see Materials and methods). 
*For each substrate and genotype, the number of formed outgrowths/plated
embryos is indicated.
†None of the Cdx2–/– embryos formed an outgrowth; number in parentheses
indicates number of embryos showing attached parietal endoderm cells.
Fig. 5. Oct4 and Nanog are expressed in outer cells of Cdx2–/–
blastocysts. (A,B) Fluorescent in situ hybridization of Oct4 (red) and
Cdx2 (blue), and YOYO-1 nuclear dye (green). (A) Cdx2+/– or
Cdx2+/+ blastocyst. (B) Cdx2–/– blastocyst. Each panel is a composite
image of single confocal optical sections. (C,D) Fluorescent whole-
mount in situ hybridization of Nanog (red) and YOYO-1 (green).
Each panel is a composite projected image of two confocal optical
sections. (C) Cdx2+/+ blastocyst. (D) Cdx2–/– blastocyst. Scale bars:
20 µm.
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fold in the ICM and TE, respectively, compared with their
Cdx2+/+ or Cdx2+/– littermates (Fig. 7C). We thus conclude that
lack of Cdx2 leads to increased cell death at the expanded
blastocyst stage, predominantly in the outer cell layer.
Eomes is required later than Cdx2 in the trophoblast
lineage
Eomes encodes a T-box TF and is expressed early in the
trophoblast lineage (Ciruna and Rossant, 1999; Russ et al.,
2000), including the TE of the blastocyst stage (Hancock et al.,
1999). Previous analysis of Eomes knockout embryos has
shown that Eomes–/– embryos survive to 6.5-7.5 dpc in utero,
but display a blastocyst-like morphology and fail to form
trophoblast outgrowths in vitro (Russ et al., 2000). However,
the exact stage of trophoblast development affected by loss of
Eomes was not clear. We generated a targeted allele of Eomes
(Fig. 8A) and confirmed that blastocyst-like embryos could be
identified in a quarter of the deciduae from Eomes+/–
intercrosses (Fig. 8D,H). Thus, Eomes mutants, unlike Cdx2
mutants, can induce a decidual response. To evaluate the degree
of TE differentiation in Eomes–/– embryos we examined the
expression of TE-specific markers (Fig. 8). Embryos from
Eomes+/– intercrosses were dissected at 4.5-4.75 dpc and Oct4
and Cdx2 expression analyzed. TE-specific expression of Cdx2
and ICM-restricted expression of Oct4 were observed in
Eomes–/– embryos (n=2), comparable with the expression
pattern in Eomes+/+ and Eomes+/– littermates (n=3; Fig. 8B,F).
However, despite the relatively normal appearance of the
Eomes mutant blastocysts, TE differentiation at the time of
implantation was compromised, as measured by the expression
of integrin α7, which was undetectable in the Eomes–/–
blastocysts (two mutants, three non-mutants; Fig. 8C,G).
To determine whether the TE of Eomes–/– embryos can
differentiate in vitro, blastocysts from Eomes+/– intercrosses
were assayed for trophoblast outgrowth formation (Fig. 8E,I).
As previously reported (Russ et al., 2000), Eomes–/– blastocysts
failed to attach and form a TE outgrowth (Fig. 8I).
Morphologically we observed that the Eomes–/– blastocysts
remained as fully expanded blastocysts after 96 hours of
culture, unlike Cdx2–/– embryos, which eventually collapse. We
examined the expression of additional TE markers by a semi-
quantitative RT-PCR analysis from individual in vitro cultured
blastocysts from Eomes+/– intercrosses, as described above for
Cdx2 analysis. Analysis was performed on embryos at 24
hours, 96 hours and 120 hours of culture (Fig. 8J). The analysis
indicated that in the absence of Eomes, Cdx2 and Fgfr2 are still
expressed (Beck et al., 1995; Haffner-Krausz et al., 1999).
However, the expression of Hand1 and Pl1 (Cross et al., 1995;
Faria et al., 1991), markers of differentiated trophoblast giant
cells, was undetectable in Eomes presumptive null embryos
(Fig. 8J). We also attempted to derive TS cell lines from
blastocysts obtained from Eomes+/– intercrosses (Tanaka et al.,
1998). Twenty-one TS cell lines were derived from a total of
36 blastocysts initially cultured. However, none was Eomes–/–
by genotype.
Fig. 6. Nanog is not downregulated in the outer cells of Cdx2–/–
embryos. (A) Immunolocalization of Nanog in Cdx2+/+ morula. (B)
Nanog in Cdx2–/– morula, littermate of embryo shown in A. Nanog is
detected in inner and outer cells in non-mutant and mutant morulae.
(C) Nanog in Cdx2+/+ in early blastocyst. Low levels of Nanog can be
detected in occasional TE nuclei (arrowhead), but is largely
downregulated in the TE by this stage. (D) Nanog in Cdx2–/– early
blastocyst. Nanog expression persists in TE cells in Cdx2 mutants.
All panels are projections of multiple optical sections. Fig. 7. Cultured Cdx2
–/– embryos exhibit excessive cell death at the
expanded blastocyst stage. (A-B′) Composite images of single
confocal optical sections superimposed on DIC images. Zona
pellucida-free eight-cell stage embryos from Cdx2+/– intercrosses
were cultured for 48 hours followed by TUNEL analysis. (A)
Cdx2+/–; TUNEL-positive nuclei were detected in the ICM. (B,B′)
Cdx2–/– blastocyst; TUNEL-positive nuclei were observed in the
ICM and TE. (B′) Optical section taken at a different level of the
embryo in B. Scale bars: 25 µm. (C) The number of TUNEL-positive
nuclei in the ICM and TE of Cdx2+/+ or Cdx2+/– embryos (n=16) and
Cdx2–/– embryos (n=7) was scored from confocal optical sections of
individual embryos following TUNEL staining. The values plotted
represent the mean number of TUNEL-positive nuclei (±s.e.m.). The
increase in the number of TUNEL positive nuclei in the ICM and TE
in Cdx2–/– embryos compared with Cdx2+/– or Cdx2+/+ embryos was
significant at P<0.001 using Student’s t-test analysis.
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Discussion
Cdx2 is required for the development of a functional
trophectoderm
Cdx2–/– blastocysts cavitate normally, around the same time as
non-mutant littermates, and are initially able to expand.
However, the expanded blastocoel is not maintained, embryos
fail to hatch from the zona pellucida and mutants eventually
collapse into a ball of cells. Cdx2 mutants fail to implant in
vivo or form a trophoblast giant cell outgrowth when cultured
without their zona pellucida. Analysis of epithelial markers,
such as tight and adherens junction components, suggests that
polarized epithelial integrity of the outer cells is initially
established, but fails to be maintained by the late blastocyst
stage in Cdx2–/– mutants, suggestive of a block in further TE
differentiation and maintenance.
Examination of markers of TE differentiation in non-
attached mutant embryos revealed no expression of Hand1 and
Pl1, markers of trophoblast giant cells. The trophectoderm
differentiation marker Pl1 can be detected in cultured wild-
type blastocysts, even if they do not form outgrowths (Nieder
and Nagy, 1991). Thus, the failure of cultured Cdx2–/–
blastocysts to express Pl1 is not secondary to outgrowth failure
but represents a block in trophectoderm differentiation.
Expression of the trophoblast stem cell marker, Eomes, was
also strongly reduced and TS cell lines could not be derived
from Cdx2–/– embryos, suggesting a block in TS cell formation
or self-renewal. As both stem cell and giant cell fate are
blocked by absence of Cdx2, this TF must play a key role in
early maintenance of the integrity and function of the
blastocyst TE.
Cdx2 is required for lineage-restricted expression of
Oct4 and Nanog
In Cdx2–/– embryos, Oct4 and Nanog are not downregulated in
outer cells, and persist in these cells even by 4.5 dpc. Thus, it
appears that Cdx2 plays a primary role in specifying the fate
of the trophectoderm cells by restricting the expression of Oct4
and Nanog to the ICM. One explanation for the failure of TE
development in Cdx2–/– mutants could then be that the outside
cells initiate blastocyst epithelium formation but do not
properly specify TE fate. Retention of pluripotency-associated
markers in the outer cells might indicate transformation of
outer cells to a more ICM-like phenotype. However, it is not
clear whether, in the absence of Cdx2, outside cells are actually
converted to ICM cells. Rather, increased levels of TUNEL
staining in the outer cells of Cdx2 mutants suggest that the
misexpression of Oct4 and Nanog is incompatible with
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Fig. 8. Eomesodermin (Eomes) homozygous mutant embryos are
viable through 6.0 dpc, but fail to differentiate the trophoblast
lineage in vivo and in culture. (A) Targeted disruption of Eomes
gene. (Top panel) Restriction maps of the mouse Eomes gene, the
targeting construct and the predicted structure of the targeted Eomes
allele. The six exons are shown as boxes, with the filled region
indicating T-domain. In the targeting construct, a 4.3 kb segment
containing two-thirds of the T-domain and the C-terminal half of
Eomes was replaced with a PGK-neo cassette (neo), which was
flanked by a 3.4 kb of Eomes 5′ and 2.1 kb of Eomes 3′ sequences
(black boxes). An MC1-tk cassette (tk) was used as negative selector.
Arrows indicate the position of primers for PCR-based genotyping.
(Bottom panel) Representative Southern blot analysis of tail DNA
isolated from pups. The 5′ probe recognizes 15.0 kb wild-type and
10.7 kb targeted EcoRV fragments. (B,F) Immunolocalization of
Cdx2 (red) and Oct4 (blue) in 4.5 dpc embryos from Eomes+/–
intercrosses. (B) Eomes+/–; (F) Eomes–/–. (C,G) Immunolocalization
of integrin α7 (blue) and YOYO-1 (green) in 4.75 dpc embryos from
Eomes+/– intercrosses. Integrin α7 is expressed in the trophectoderm
of the Eomes+/– embryo (arrowheads in C), but is undetectable in the
Eomes–/– embryo (G). (D,H) Morphology of embryos from Eomes+/–
intercrosses at 6.0 dpc. (D) Presumptive Eomes+/+ or Eomes+/–
embryo. (H) Presumptive Eomes–/– embryo; arrowhead indicates an
ICM-like structure. (E,I) Trophoblast outgrowth assay. Blastocysts
(3.5 dpc) from Eomes+/– intercrosses were cultured individually in
tissue culture plates uncoated or pre-coated with ECM substrate for
96 hours. (E) Outgrowth of an Eomes+/+ embryo. (I) Eomes–/–
embryo failed to attach, and remained as an expanded blastocyst.
Scale bars: 20 µm for C,F,G; 25µm for B,I; 40 µm for D,E,H. GC,
trophoblast giant cells. (J) Semi-quantitative RT-PCR analysis for
trophoblast markers in individual embryos from Eomes+/–
intercrosses. RNA was extracted from individually cultured
blastocysts and analyzed by RT-PCR. Culture conditions are
indicated genotype deduced from the absence or presence of an
Eomes-specific PCR product is indicated over each lane.
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maintenance of the TE phenotype, leading to subsequent cell
death. The remaining ICM cells in 4.5 dpc Cdx2–/– blastocysts
can continue to develop into embryoid body type structures
with distinct epiblast and primitive endoderm layers.
Moreover, it is possible to generate Cdx2–/– ES cells and to
derive early somite embryos from them (Chawengsaksophak
et al., 2004).
Cdx2 expression marks TE precursors prior to
blastocyst formation
Cdx2 expression is restricted to prospective TE cells prior to
restriction of Oct4/Nanog to the ICM, consistent with a role in
downregulation of Oct4/Nanog in the TE. The timing and
expression domains of Cdx2 and Oct4/Nanog in normal
embryos, and the upregulation of Oct4/Nanog in Cdx2 mutants
might suggest that Cdx2 restriction to outer cells is the primary
driver of the divergence of ICM and TE lineages. Consistent
with this, Niwa et al. show that overexpression of Cdx2 is
sufficient to drive differentiation of ES cells into trophoblast
cells, but Cdx2 is not necessary for trophoblast differentiation
if Oct4 is directly downregulated (H. Niwa, unpublished).
Early segregation of Cdx2 to the outer cells of the morula
and early blastocyst may thus be key for initiating TE/ICM
specification. Whether Cdx2 can directly regulate Oct4/Nanog
at the transcriptional level or acts post-transcriptionally is
currently unknown. What drives the segregation of Cdx2 to the
outside cells also remains to be determined, although the
similar restricted expression pattern of Fgfr2 in the outside
cells (Haffner-Krausz et al., 1999) and the known role for this
signalling pathway in promoting TE development (Chai et al.,
1998) suggests that FGF signalling may be important upstream
of Cdx2.
Why does blastocoel initiate in the absence of
Cdx2?
Although Cdx2 has a pivotal role in the development of a fully
functional TE and downregulation of the pluripotency-
associated genes, blastocoel initiation does not require zygotic
Cdx2. Nor does it seem that TE initiation can be explained by
persistent maternal Cdx2 protein, as little or no Cdx2 protein
was observed in Cdx2–/– morulae and early blastocysts.
Other factors could support the initial development of the
TE epithelium in the absence of Cdx2. Two additional
members of the Caudal-type TF family, Cdx1 and Cdx4, are
found in the mouse. Previous analyses indicated that the three
Cdx family members share partially overlapping expression
patterns and functions along the embryonic axis, but only Cdx2
is expressed in the postimplantation trophoblast, making
redundancy with other Cdx genes unlikely (Beck et al., 1995;
Gamer and Wright, 1993; Meyer and Gruss, 1993; van den
Akker et al., 2002).
Eomes is expressed in the TE of the blastocyst, and persists
in the proximal region of the ExE in early post-implantation
stages. Similarity of expression with Cdx2 might suggest
overlapping functions. However, we show that both phenotypic
and expression analysis place Cdx2 upstream of zygotic Eomes
in TE development and make it unlikely that the two genes are
acting redundantly in the initial specification of the TE
epithelium. Unlike Cdx2 mutant embryos, Eomes–/– blastocysts
cause a decidual reaction and show full expansion and
maintenance of the blastocoel in vitro, indicative of a
functional TE (Russ et al., 2000) (this study). Cdx2 is
expressed normally and Oct4 expression is segregated to the
ICM, indicating that Eomes is not required for initial ICM/TE
separation. However, neither trophoblast giant cells nor TS
cells can develop from Eomes mutants and markers of TE
differentiation are lost. This does not exclude overlapping
functions for the two genes later in TS cell development, as
may be indicated by the failure to obtain TS cells in both cases.
Elucidation of their later roles will require timed conditional
inactivation studies.
In conclusion, our studies have uncovered that Cdx2 and
Eomes are key TFs required at distinct stages during early TE
lineage development. Eomes is required for TE differentiation
and proliferation beyond the expanded blastocyst stage, while
Cdx2 is the earliest TE-specific TF essential for TE function
and establishment of the trophoblast lineage, as well as for the
lineage restricted expression of the pluripotency markers, Oct4
and Nanog. Therefore, cell fate specification in the
preimplantation embryo relies on positive acting TFs in both
the ICM and TE lineages. Elucidation of the regulatory
mechanisms that underlie the restricted expression and
feedback loops between these TFs during morula stages should
shed light on how cell fate specification is initiated in the
preimplantation embryo.
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